REQUEST A DEMO
Total
USD $0.00
Search more companies

Boksan Nice Pharm Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Boksan Nice Pharm Co.,Ltd. Profile Updated: December 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Boksan Nice Pharm Co.,Ltd. is an enterprise in South Korea, with the main office in Busan. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on May 26, 2007. Boksan Nice Pharm Co.,Ltd. currently employs 285 (2024) people. From the latest financial highlights, Boksan Nice Pharm Co.,Ltd. reported a net sales revenue increase of 0.16% in 2023. Its total assets grew by 3.8% over the same period. Boksan Nice Pharm Co.,Ltd.’s net profit margin increased by 0.2% in 2023.

Headquarters
53, Jaseong-ro 140beon-gil Dong-gu Busan
Busan; Busan;

Contact Details: Purchase the Boksan Nice Pharm Co.,Ltd. report to view the information.

Website: http://www.nicepharm.com/

Basic Information
Total Employees:
Purchase the Boksan Nice Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Boksan Nice Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Boksan Nice Pharm Co.,Ltd. report to view the information.
Incorporation Date:
May 26, 2007
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
45%
Purchase this report to view the information.
21.7%
Purchase this report to view the information.
15.9%
Subsidiaries
Boksan Pharm Co.,Ltd.
3.3%
Boksan Pharmacy Co.,Ltd.
Company Performance
Financial values in the chart are available after Boksan Nice Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
0.16%
Total operating revenue
0.16%
Operating profit (EBIT)
23.67%
EBITDA
25.04%
Net Profit (Loss) for the Period
50.44%
Total assets
3.8%
Total equity
3.79%
Operating Profit Margin (ROS)
0.17%
Net Profit Margin
0.2%
Return on Equity (ROE)
1.46%
Debt to Equity Ratio
2.62%
Quick Ratio
-0.1%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?